Airports have always been built around convenience. Moving people quickly through the term...
Parade aims to feature only the best products and services. If you buy something via one o...
People in the Russian city of Tuapse are worried about the effects of an oil refinery fire...
Wave Season 2026 has officially wrapped, and the latest shopping data from Cruise Critic r...
The Lebanese government wants Hezbollah to disarm as it aims for a state monopoly on weapo...
Countries
Opinion
California Governor’s debate reveals major problem — as all the candidates are ranked
Mamdani made Ken Griffin a target — and cemented NYC’s death spiral
Murphy’s ‘sarcastic’ post: Letters to the Editor — April 24, 2026
Mamdani & Chi Ossé’s performances this week prove they’re in the wrong field
Teen girl stomped on NYC street shows a generation abandoned to phones and porn
-
Independent ( Yemen ) 2026/4/2The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
-
PR Newswire ( Middle East ) 2026/3/28Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz mon...
-
Gizmodo ( Middle East ) 2026/1/9People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
-
Quartz ( Middle East ) 2025/10/6European Association for the Study of Obesity says the drugs are so effective, they should be used for almost all obesity patients
-
Los Angeles Daily News ( Middle East ) 2025/5/12By Naomi Kresge | BloombergEli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nord...
-
Quartz ( Middle East ) 2025/5/12Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s d...
-
News10NBC ( Middle East ) 2025/5/12People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head...
-
Quartz ( Middle East ) 2025/4/1Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and...
- Ukiah Daily Journal ( Middle East ) 2025/3/5
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.Related ArticlesHealth |...
